NOS2 and prostate neoplasm: However, a case-control study nested in a prostate cancer cohort from Sweden observed that high compared to low/negative iNOS immunoreactivity in prostate tumor epithelial cells was associated with a strongly increased 10-year prostate cancer mortality (OR (95% CI), 3.80 (1.45-9.97)) [20].